• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SENTINEL CEREBRAL PROTECTION SYSTEM (US); EMBOLIC PROTECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SENTINEL CEREBRAL PROTECTION SYSTEM (US); EMBOLIC PROTECTION DEVICE Back to Search Results
Model Number CMS15-10C-US
Device Problems Break (1069); Difficult to Remove (1528)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/13/2021
Event Type  malfunction  
Event Description
It was reported that the distal filter was removed unsheathed.Procedure summary: a sentinel cerebral protection system was advanced and deployed in the patient's type 1 aortic arch in preparation for a transcatheter aortic valve replacement (tavr) procedure.During retrieval of the distal filter, the distal filter hypotube fractured and the distal filter could not be re-sheathed.The sentinel cerebral protection system was then removed through the introducer sheath in tact with the proximal filter sheathed and the distal filter unsheathed.The tavr procedure was not completed due to perforation of the left ventricle unrelated to the sentinel cerebral protection system device.
 
Manufacturer Narrative
H3: device eval by manufacturer: the device was returned to boston scientific(bsc) and analyzed by a bsc quality engineer.Visual analysis of returned device revealed the device was returned with a guidewire loaded, the distal filter slider (#3) was bent/kinked, the proximal filter sheathed, the articulating distal sheath (ads) was relaxed and kinked, the distal filter was un-sheathed.Xray analysis of the returned device revealed inner member buckling.Functional testing of the returned device revealed the distal filter could not be sheathed using the distal filter slider (#3) due to inner member buckling.
 
Event Description
It was reported that the distal filter was removed unsheathed.Procedure summary: a sentinel cerebral protection system was advanced and deployed in the patient's type 1 aortic arch in preparation for a transcatheter aortic valve replacement (tavr) procedure.During retrieval of the distal filter, the distal filter hypotube fractured and the distal filter could not be re-sheathed.The sentinel cerebral protection system was then removed through the introducer sheath in tact with the proximal filter sheathed and the distal filter unsheathed.The tavr procedure was not completed due to perforation of the left ventricle unrelated to the sentinel cerebral protection system device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENTINEL CEREBRAL PROTECTION SYSTEM (US)
Type of Device
EMBOLIC PROTECTION DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11791175
MDR Text Key249790544
Report Number2134265-2021-05728
Device Sequence Number1
Product Code PUM
UDI-Device Identifier00863229000004
UDI-Public00863229000004
Combination Product (y/n)N
PMA/PMN Number
K192460
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Inspection
Type of Report Initial,Followup
Report Date 08/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/10/2022
Device Model NumberCMS15-10C-US
Device Catalogue NumberCMS15-10C-US
Device Lot Number0026337936
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/02/2021
Initial Date Manufacturer Received 04/13/2021
Initial Date FDA Received05/07/2021
Supplement Dates Manufacturer Received07/19/2021
Supplement Dates FDA Received08/11/2021
Patient Sequence Number1
Patient Age79 YR
-
-